Compile Data Set for Download or QSAR
Report error Found 84 Enz. Inhib. hit(s) with all data for entry = 10796
TargetSphingomyelin phosphodiesterase 3(Human)
The Johns Hopkins University

US Patent
LigandPNGBDBM570145(US11427590, Entry 62 | US20240115574, Entry 62)
Affinity DataIC50: 50nMAssay Description:The fluorescence based assay to monitor the activity of human nSMase2 in the presence or absence of potential inhibitors has been described recently....More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/7/2022
Entry Details
Go to US Patent

TargetSphingomyelin phosphodiesterase 3(Human)
The Johns Hopkins University

US Patent
LigandPNGBDBM50540386(CHEMBL4647644 | US11427590, Entry 44 | US202401155...)
Affinity DataIC50: 50nMAssay Description:The fluorescence based assay to monitor the activity of human nSMase2 in the presence or absence of potential inhibitors has been described recently....More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/7/2022
Entry Details
Go to US Patent

TargetSphingomyelin phosphodiesterase 3(Human)
The Johns Hopkins University

US Patent
LigandPNGBDBM50540378(CHEMBL4634085 | US11427590, Entry 22 | US202401155...)
Affinity DataIC50: 90nMAssay Description:The fluorescence based assay to monitor the activity of human nSMase2 in the presence or absence of potential inhibitors has been described recently....More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/7/2022
Entry Details
Go to US Patent

TargetSphingomyelin phosphodiesterase 3(Human)
The Johns Hopkins University

US Patent
LigandPNGBDBM50540363(CHEMBL4643888 | US11427590, Entry 32 | US202401155...)
Affinity DataIC50: 100nMAssay Description:The fluorescence based assay to monitor the activity of human nSMase2 in the presence or absence of potential inhibitors has been described recently....More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/7/2022
Entry Details
Go to US Patent

TargetSphingomyelin phosphodiesterase 3(Human)
The Johns Hopkins University

US Patent
LigandPNGBDBM50540376(CHEMBL4644091 | US11427590, Entry 24 | US202401155...)
Affinity DataIC50: 100nMAssay Description:The fluorescence based assay to monitor the activity of human nSMase2 in the presence or absence of potential inhibitors has been described recently....More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/7/2022
Entry Details
Go to US Patent

TargetSphingomyelin phosphodiesterase 3(Human)
The Johns Hopkins University

US Patent
LigandPNGBDBM570104(US11427590, Entry 21 | US20240115574, Entry 21)
Affinity DataIC50: 100nMAssay Description:The fluorescence based assay to monitor the activity of human nSMase2 in the presence or absence of potential inhibitors has been described recently....More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/7/2022
Entry Details
Go to US Patent

TargetSphingomyelin phosphodiesterase 3(Human)
The Johns Hopkins University

US Patent
LigandPNGBDBM50540366(CHEMBL4635335 | US11427590, Entry 37 | US202401155...)
Affinity DataIC50: 100nMAssay Description:The fluorescence based assay to monitor the activity of human nSMase2 in the presence or absence of potential inhibitors has been described recently....More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/7/2022
Entry Details
Go to US Patent

TargetSphingomyelin phosphodiesterase 3(Human)
The Johns Hopkins University

US Patent
LigandPNGBDBM50540383(CHEMBL4635273 | US11427590, Entry 25 | US202401155...)
Affinity DataIC50: 100nMAssay Description:The fluorescence based assay to monitor the activity of human nSMase2 in the presence or absence of potential inhibitors has been described recently....More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/7/2022
Entry Details
Go to US Patent

TargetSphingomyelin phosphodiesterase 3(Human)
The Johns Hopkins University

US Patent
LigandPNGBDBM50540381(CHEMBL4632415 | US11427590, Entry 30 | US202401155...)
Affinity DataIC50: 200nMAssay Description:The fluorescence based assay to monitor the activity of human nSMase2 in the presence or absence of potential inhibitors has been described recently....More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/7/2022
Entry Details
Go to US Patent

TargetSphingomyelin phosphodiesterase 3(Human)
The Johns Hopkins University

US Patent
LigandPNGBDBM50540369(CHEMBL4632713 | US11427590, Entry 19 | US202401155...)
Affinity DataIC50: 200nMAssay Description:The fluorescence based assay to monitor the activity of human nSMase2 in the presence or absence of potential inhibitors has been described recently....More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/7/2022
Entry Details
Go to US Patent

TargetSphingomyelin phosphodiesterase 3(Human)
The Johns Hopkins University

US Patent
LigandPNGBDBM50540356(CHEMBL4632464 | US11427590, Entry 17 | US202401155...)
Affinity DataIC50: 200nMAssay Description:The fluorescence based assay to monitor the activity of human nSMase2 in the presence or absence of potential inhibitors has been described recently....More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/7/2022
Entry Details
Go to US Patent

TargetSphingomyelin phosphodiesterase 3(Human)
The Johns Hopkins University

US Patent
LigandPNGBDBM50540365(CHEMBL4633254 | US11427590, Entry 34 | US202401155...)
Affinity DataIC50: 200nMAssay Description:The fluorescence based assay to monitor the activity of human nSMase2 in the presence or absence of potential inhibitors has been described recently....More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/7/2022
Entry Details
Go to US Patent

TargetSphingomyelin phosphodiesterase 3(Human)
The Johns Hopkins University

US Patent
LigandPNGBDBM50540382(CHEMBL4640034 | US11427590, Entry 23 | US202401155...)
Affinity DataIC50: 200nMAssay Description:The fluorescence based assay to monitor the activity of human nSMase2 in the presence or absence of potential inhibitors has been described recently....More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/7/2022
Entry Details
Go to US Patent

TargetSphingomyelin phosphodiesterase 3(Human)
The Johns Hopkins University

US Patent
LigandPNGBDBM50540349(CHEMBL4648675 | US11427590, Entry 9 | US2024011557...)
Affinity DataIC50: 200nMAssay Description:The fluorescence based assay to monitor the activity of human nSMase2 in the presence or absence of potential inhibitors has been described recently....More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/7/2022
Entry Details
Go to US Patent

TargetSphingomyelin phosphodiesterase 3(Human)
The Johns Hopkins University

US Patent
LigandPNGBDBM50540372(CHEMBL4648184 | US11427590, Entry 42 | US202401155...)
Affinity DataIC50: 200nMAssay Description:The fluorescence based assay to monitor the activity of human nSMase2 in the presence or absence of potential inhibitors has been described recently....More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/7/2022
Entry Details
Go to US Patent

TargetSphingomyelin phosphodiesterase 3(Human)
The Johns Hopkins University

US Patent
LigandPNGBDBM50540352(CHEMBL4643164 | US11427590, Entry 13 | US202401155...)
Affinity DataIC50: 300nMAssay Description:The fluorescence based assay to monitor the activity of human nSMase2 in the presence or absence of potential inhibitors has been described recently....More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/7/2022
Entry Details
Go to US Patent

TargetSphingomyelin phosphodiesterase 3(Human)
The Johns Hopkins University

US Patent
LigandPNGBDBM50540370(CHEMBL4639494 | US11427590, Entry 39 | US202401155...)
Affinity DataIC50: 300nMAssay Description:The fluorescence based assay to monitor the activity of human nSMase2 in the presence or absence of potential inhibitors has been described recently....More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/7/2022
Entry Details
Go to US Patent

TargetSphingomyelin phosphodiesterase 3(Human)
The Johns Hopkins University

US Patent
LigandPNGBDBM50540395(CHEMBL4648122 | US11427590, Entry 56 | US202401155...)
Affinity DataIC50: 300nMAssay Description:The fluorescence based assay to monitor the activity of human nSMase2 in the presence or absence of potential inhibitors has been described recently....More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/7/2022
Entry Details
Go to US Patent

TargetSphingomyelin phosphodiesterase 3(Human)
The Johns Hopkins University

US Patent
LigandPNGBDBM570123(US11427590, Entry 40 | US20240115574, Entry 40)
Affinity DataIC50: 300nMAssay Description:The fluorescence based assay to monitor the activity of human nSMase2 in the presence or absence of potential inhibitors has been described recently....More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/7/2022
Entry Details
Go to US Patent

TargetSphingomyelin phosphodiesterase 3(Human)
The Johns Hopkins University

US Patent
LigandPNGBDBM50540358(CHEMBL4647138 | US11427590, Entry 38 | US202401155...)
Affinity DataIC50: 300nMAssay Description:The fluorescence based assay to monitor the activity of human nSMase2 in the presence or absence of potential inhibitors has been described recently....More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/7/2022
Entry Details
Go to US Patent

TargetSphingomyelin phosphodiesterase 3(Human)
The Johns Hopkins University

US Patent
LigandPNGBDBM50540375(CHEMBL4644815 | US11427590, Entry 27 | US202401155...)
Affinity DataIC50: 300nMAssay Description:The fluorescence based assay to monitor the activity of human nSMase2 in the presence or absence of potential inhibitors has been described recently....More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/7/2022
Entry Details
Go to US Patent

TargetSphingomyelin phosphodiesterase 3(Human)
The Johns Hopkins University

US Patent
LigandPNGBDBM50540397(CHEMBL4639393 | US11427590, Entry 59 | US202401155...)
Affinity DataIC50: 300nMAssay Description:The fluorescence based assay to monitor the activity of human nSMase2 in the presence or absence of potential inhibitors has been described recently....More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/7/2022
Entry Details
Go to US Patent

TargetSphingomyelin phosphodiesterase 3(Human)
The Johns Hopkins University

US Patent
LigandPNGBDBM50540373(CHEMBL4645128 | US11427590, Entry 43 | US202401155...)
Affinity DataIC50: 300nMAssay Description:The fluorescence based assay to monitor the activity of human nSMase2 in the presence or absence of potential inhibitors has been described recently....More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/7/2022
Entry Details
Go to US Patent

TargetSphingomyelin phosphodiesterase 3(Human)
The Johns Hopkins University

US Patent
LigandPNGBDBM50540371(CHEMBL4646637 | US11427590, Entry 41 | US202401155...)
Affinity DataIC50: 300nMAssay Description:The fluorescence based assay to monitor the activity of human nSMase2 in the presence or absence of potential inhibitors has been described recently....More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/7/2022
Entry Details
Go to US Patent

TargetSphingomyelin phosphodiesterase 3(Human)
The Johns Hopkins University

US Patent
LigandPNGBDBM50540385(CHEMBL4649470 | US11427590, Entry 26 | US202401155...)
Affinity DataIC50: 300nMAssay Description:The fluorescence based assay to monitor the activity of human nSMase2 in the presence or absence of potential inhibitors has been described recently....More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/7/2022
Entry Details
Go to US Patent

TargetSphingomyelin phosphodiesterase 3(Human)
The Johns Hopkins University

US Patent
LigandPNGBDBM50540380(CHEMBL4647259 | US11427590, Entry 29 | US202401155...)
Affinity DataIC50: 400nMAssay Description:The fluorescence based assay to monitor the activity of human nSMase2 in the presence or absence of potential inhibitors has been described recently....More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/7/2022
Entry Details
Go to US Patent

TargetSphingomyelin phosphodiesterase 3(Human)
The Johns Hopkins University

US Patent
LigandPNGBDBM50540367(CHEMBL4645484 | US11427590, Entry 36 | US202401155...)
Affinity DataIC50: 400nMAssay Description:The fluorescence based assay to monitor the activity of human nSMase2 in the presence or absence of potential inhibitors has been described recently....More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/7/2022
Entry Details
Go to US Patent

TargetSphingomyelin phosphodiesterase 3(Human)
The Johns Hopkins University

US Patent
LigandPNGBDBM50540364(CHEMBL4636705 | US11427590, Entry 33 | US202401155...)
Affinity DataIC50: 400nMAssay Description:The fluorescence based assay to monitor the activity of human nSMase2 in the presence or absence of potential inhibitors has been described recently....More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/7/2022
Entry Details
Go to US Patent

TargetSphingomyelin phosphodiesterase 3(Human)
The Johns Hopkins University

US Patent
LigandPNGBDBM570091(US11427590, Entry 8 | US20240115574, Entry 8)
Affinity DataIC50: 400nMAssay Description:The fluorescence based assay to monitor the activity of human nSMase2 in the presence or absence of potential inhibitors has been described recently....More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/7/2022
Entry Details
Go to US Patent

TargetSphingomyelin phosphodiesterase 3(Human)
The Johns Hopkins University

US Patent
LigandPNGBDBM570095(US11427590, Entry 12 | US20240115574, Entry 12)
Affinity DataIC50: 400nMAssay Description:The fluorescence based assay to monitor the activity of human nSMase2 in the presence or absence of potential inhibitors has been described recently....More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/7/2022
Entry Details
Go to US Patent

TargetSphingomyelin phosphodiesterase 3(Human)
The Johns Hopkins University

US Patent
LigandPNGBDBM50540399(CHEMBL4646175 | US11427590, Entry 60 | US202401155...)
Affinity DataIC50: 400nMAssay Description:The fluorescence based assay to monitor the activity of human nSMase2 in the presence or absence of potential inhibitors has been described recently....More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/7/2022
Entry Details
Go to US Patent

TargetSphingomyelin phosphodiesterase 3(Human)
The Johns Hopkins University

US Patent
LigandPNGBDBM50540393(CHEMBL4645616 | US11427590, Entry 52 | US202401155...)
Affinity DataIC50: 500nMAssay Description:The fluorescence based assay to monitor the activity of human nSMase2 in the presence or absence of potential inhibitors has been described recently....More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/7/2022
Entry Details
Go to US Patent

TargetSphingomyelin phosphodiesterase 3(Human)
The Johns Hopkins University

US Patent
LigandPNGBDBM50540351(CHEMBL4635005 | US11427590, Entry 11 | US202401155...)
Affinity DataIC50: 500nMAssay Description:The fluorescence based assay to monitor the activity of human nSMase2 in the presence or absence of potential inhibitors has been described recently....More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/7/2022
Entry Details
Go to US Patent

TargetSphingomyelin phosphodiesterase 3(Human)
The Johns Hopkins University

US Patent
LigandPNGBDBM50540377(CHEMBL4640489 | US11427590, Entry 28 | US202401155...)
Affinity DataIC50: 500nMAssay Description:The fluorescence based assay to monitor the activity of human nSMase2 in the presence or absence of potential inhibitors has been described recently....More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/7/2022
Entry Details
Go to US Patent

TargetSphingomyelin phosphodiesterase 3(Human)
The Johns Hopkins University

US Patent
LigandPNGBDBM50540350(CHEMBL4643840 | US11427590, Entry 10 | US202401155...)
Affinity DataIC50: 500nMAssay Description:The fluorescence based assay to monitor the activity of human nSMase2 in the presence or absence of potential inhibitors has been described recently....More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/7/2022
Entry Details
Go to US Patent

TargetSphingomyelin phosphodiesterase 3(Human)
The Johns Hopkins University

US Patent
LigandPNGBDBM50540392(CHEMBL4649016 | US11427590, Entry 51 | US202401155...)
Affinity DataIC50: 600nMAssay Description:The fluorescence based assay to monitor the activity of human nSMase2 in the presence or absence of potential inhibitors has been described recently....More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/7/2022
Entry Details
Go to US Patent

TargetSphingomyelin phosphodiesterase 3(Human)
The Johns Hopkins University

US Patent
LigandPNGBDBM50540348(CHEMBL4634886 | US11427590, Entry 7 | US2024011557...)
Affinity DataIC50: 600nMAssay Description:The fluorescence based assay to monitor the activity of human nSMase2 in the presence or absence of potential inhibitors has been described recently....More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/7/2022
Entry Details
Go to US Patent

TargetSphingomyelin phosphodiesterase 3(Human)
The Johns Hopkins University

US Patent
LigandPNGBDBM570114(US11427590, Entry 31 | US20240115574, Entry 31-(MS...)
Affinity DataIC50: 700nMAssay Description:The fluorescence based assay to monitor the activity of human nSMase2 in the presence or absence of potential inhibitors has been described recently....More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/7/2022
Entry Details
Go to US Patent

TargetSphingomyelin phosphodiesterase 3(Human)
The Johns Hopkins University

US Patent
LigandPNGBDBM50540390(CHEMBL4642381 | US11427590, Entry 49 | US202401155...)
Affinity DataIC50: 700nMAssay Description:The fluorescence based assay to monitor the activity of human nSMase2 in the presence or absence of potential inhibitors has been described recently....More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/7/2022
Entry Details
Go to US Patent

TargetSphingomyelin phosphodiesterase 3(Human)
The Johns Hopkins University

US Patent
LigandPNGBDBM50540357(CHEMBL4648938 | US11427590, Entry 18 | US202401155...)
Affinity DataIC50: 700nMAssay Description:The fluorescence based assay to monitor the activity of human nSMase2 in the presence or absence of potential inhibitors has been described recently....More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/7/2022
Entry Details
Go to US Patent

TargetSphingomyelin phosphodiesterase 3(Human)
The Johns Hopkins University

US Patent
LigandPNGBDBM570137(US11427590, Entry 54 | US20240115574, Entry 54)
Affinity DataIC50: 700nMAssay Description:The fluorescence based assay to monitor the activity of human nSMase2 in the presence or absence of potential inhibitors has been described recently....More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/7/2022
Entry Details
Go to US Patent

TargetSphingomyelin phosphodiesterase 3(Human)
The Johns Hopkins University

US Patent
LigandPNGBDBM50540398(CHEMBL4646834 | US11427590, Entry 57 | US202401155...)
Affinity DataIC50: 700nMAssay Description:The fluorescence based assay to monitor the activity of human nSMase2 in the presence or absence of potential inhibitors has been described recently....More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/7/2022
Entry Details
Go to US Patent

TargetSphingomyelin phosphodiesterase 3(Human)
The Johns Hopkins University

US Patent
LigandPNGBDBM50540396(CHEMBL4643224 | US11427590, Entry 58 | US202401155...)
Affinity DataIC50: 700nMAssay Description:The fluorescence based assay to monitor the activity of human nSMase2 in the presence or absence of potential inhibitors has been described recently....More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/7/2022
Entry Details
Go to US Patent

TargetSphingomyelin phosphodiesterase 3(Human)
The Johns Hopkins University

US Patent
LigandPNGBDBM50540355(CHEMBL4639208 | US11427590, Entry 16 | US202401155...)
Affinity DataIC50: 800nMAssay Description:The fluorescence based assay to monitor the activity of human nSMase2 in the presence or absence of potential inhibitors has been described recently....More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/7/2022
Entry Details
Go to US Patent

TargetSphingomyelin phosphodiesterase 3(Human)
The Johns Hopkins University

US Patent
LigandPNGBDBM50540405(CHEMBL4636748 | US11427590, Entry 61 | US202401155...)
Affinity DataIC50: 900nMAssay Description:The fluorescence based assay to monitor the activity of human nSMase2 in the presence or absence of potential inhibitors has been described recently....More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/7/2022
Entry Details
Go to US Patent

TargetSphingomyelin phosphodiesterase 3(Human)
The Johns Hopkins University

US Patent
LigandPNGBDBM50540353(CHEMBL4633305 | US11427590, Entry 14 | US202401155...)
Affinity DataIC50: 900nMAssay Description:The fluorescence based assay to monitor the activity of human nSMase2 in the presence or absence of potential inhibitors has been described recently....More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/7/2022
Entry Details
Go to US Patent

TargetSphingomyelin phosphodiesterase 3(Human)
The Johns Hopkins University

US Patent
LigandPNGBDBM50540362(CHEMBL4649068 | US11427590, Entry 35 | US202401155...)
Affinity DataIC50: 900nMAssay Description:The fluorescence based assay to monitor the activity of human nSMase2 in the presence or absence of potential inhibitors has been described recently....More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/7/2022
Entry Details
Go to US Patent

TargetSphingomyelin phosphodiesterase 3(Human)
The Johns Hopkins University

US Patent
LigandPNGBDBM50540394(CHEMBL4637546 | US11427590, Entry 53 | US202401155...)
Affinity DataIC50: 900nMAssay Description:The fluorescence based assay to monitor the activity of human nSMase2 in the presence or absence of potential inhibitors has been described recently....More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/7/2022
Entry Details
Go to US Patent

TargetSphingomyelin phosphodiesterase 3(Human)
The Johns Hopkins University

US Patent
LigandPNGBDBM50540354(CHEMBL4633477 | US11427590, Entry 15 | US202401155...)
Affinity DataIC50: 1.00E+3nMAssay Description:The fluorescence based assay to monitor the activity of human nSMase2 in the presence or absence of potential inhibitors has been described recently....More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/7/2022
Entry Details
Go to US Patent

TargetSphingomyelin phosphodiesterase 3(Human)
The Johns Hopkins University

US Patent
LigandPNGBDBM570162(US11427590, Entry 42-PROV | US20240115574, Entry 4...)
Affinity DataIC50: 1.00E+3nMAssay Description:The fluorescence based assay to monitor the activity of human nSMase2 in the presence or absence of potential inhibitors has been described recently....More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/7/2022
Entry Details
Go to US Patent

Displayed 1 to 50 (of 84 total ) | Next | Last >>
Jump to: